163 related articles for article (PubMed ID: 20184776)
1. Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.
Yunxia Z; Jun C; Guanshan Z; Yachao L; Xueke Z; Jin L
BMC Med Genet; 2010 Feb; 11():34. PubMed ID: 20184776
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.
Shen H; Yuan Y; Hu HG; Zhong X; Ye XX; Li MD; Fang WJ; Zheng S
World J Gastroenterol; 2011 Feb; 17(6):809-16. PubMed ID: 21390154
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].
Sun LN; Luan HL; Zang FL; Wang M; Dong N; Guo Y; Sun BC; Zhan ZL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):667-70. PubMed ID: 21122380
[TBL] [Abstract][Full Text] [Related]
4. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
5. Mutations in K-ras and epidermal growth factor receptor expression in Korean patients with stages III and IV colorectal cancer.
Lee WS; Baek JH; Lee JN; Lee WK
Int J Surg Pathol; 2011 Apr; 19(2):145-51. PubMed ID: 21474505
[TBL] [Abstract][Full Text] [Related]
6. Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation status.
Dong X; Zhao X; Hao Y; Wei Y; Yin Q; Du J
Clin Lung Cancer; 2013 Nov; 14(6):680-7. PubMed ID: 23910066
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer.
Li Z; Liu XW; Chi ZC; Sun BS; Cheng Y; Cheng LW
PLoS One; 2015; 10(5):e0101019. PubMed ID: 25950441
[TBL] [Abstract][Full Text] [Related]
8. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K
Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128
[TBL] [Abstract][Full Text] [Related]
11. [Study on point mutations of K-ras gene in non-small cell lung cancer in Guangxi].
Zhong W; Chen M; Xian L; Li M
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):507-11. PubMed ID: 21645454
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of K-ras and BRAF in Thai colorectal cancer and their prognostic value.
Chaiyapan W; Duangpakdee P; Boonpipattanapong T; Kanngern S; Sangkhathat S
Asian Pac J Cancer Prev; 2013; 14(1):329-32. PubMed ID: 23534748
[TBL] [Abstract][Full Text] [Related]
13. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
Zekri J; Al-Shehri A; Mahrous M; Al-Rehaily S; Darwish T; Bassi S; El Taani H; Al Zahrani A; Elsamany S; Al-Maghrabi J; Sadiq BB
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218784
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
Shigematsu H; Lin L; Takahashi T; Nomura M; Suzuki M; Wistuba II; Fong KM; Lee H; Toyooka S; Shimizu N; Fujisawa T; Feng Z; Roth JA; Herz J; Minna JD; Gazdar AF
J Natl Cancer Inst; 2005 Mar; 97(5):339-46. PubMed ID: 15741570
[TBL] [Abstract][Full Text] [Related]
15. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
16. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
17. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
Wang JY; Hsieh JS; Lu CY; Yu FJ; Wu JY; Chen FM; Huang CJ; Lin SR
Hepatogastroenterology; 2007 Dec; 54(80):2259-65. PubMed ID: 18265644
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
19. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
Han SW; Kim TY; Jeon YK; Hwang PG; Im SA; Lee KH; Kim JH; Kim DW; Heo DS; Kim NK; Chung DH; Bang YJ
Clin Cancer Res; 2006 Apr; 12(8):2538-44. PubMed ID: 16638863
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
Jeon CH; Lee HI; Shin IH; Park JW
Int J Colorectal Dis; 2008 Jan; 23(1):29-35. PubMed ID: 17704924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
